| Lindsey Redoutey, LPCA | |
|
201 22nd St, Ashland, KY 41101-7803 | |
| (866) 233-1955 | |
| Not Available |
| Full Name | Lindsey Redoutey |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 201 22nd St, Ashland, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598473886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 280756 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Redoutey, LPCA Po Box 790, Ashland, KY 41105-0790 Ph: () - | Lindsey Redoutey, LPCA 201 22nd St, Ashland, KY 41101-7803 Ph: (866) 233-1955 |
News Archive
The Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbr-ck Center for Molecular Medicine (MDC) in Berlin, Germany, will be the first academic research institution in Continental Europe to acquire a novel DNA sequencer enabling the sequencing of single DNA molecules in real time.
Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to Dr Martin Reck, Chief Oncology Physician in the Department of Thoracic Oncology, Hospital Grosshansdorf, Germany. Reck's comments came as the results from the POPLAR and BIRCH studies showing the first results of efficacy with atezolizumab across lines were presented at the European Cancer Congress 2015 (ECC 2015) in Vienna, Austria.
A new position statement by the European Menopause and Andropause Society published in the journal Maturitas provides a pathway with the latest post-reproductive health strategies, with the aim of optimizing care at an international scale.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
Having a family history of breast cancer can lead some women to wonder if the risk is out of their control. However, a study of more than 85,000 postmenopausal women, published in BioMed Central's open access journal Breast Cancer Research, observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for those with and without a family history of the disease.
› Verified 1 days ago
Brandi Dunn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Kenneth Kennedy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 201 22nd St, Ashland, KY 41101 Phone: 606-324-1141 | |
Ashley Hamm, MHA INTERN Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Melissa Fannin, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Lansdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Cynthia Lynn Barker, L.P.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 10730 Midland Trail Rd, Ashland, KY 41102 Phone: 606-928-0150 | |
Michelle Horton, PSS Counselor Medicare: Not Enrolled in Medicare Practice Location: 201 22nd St, Ashland, KY 41101 Phone: 606-324-1141 Fax: 606-325-2525 | |
Brittany Winters, LPCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-8850 |